Tardive nocturnal akathisia due to clozapine treatment

International Journal of Psychiatry in Medicine

Volumn 35, Issue 2, 2005, Pages 207-211

  Kyriakos, Dimitris ^a   Bozikas, Vasilis P ^a,b   Garyfallos, George ^a   Lavrentiadis, Grigoris ^a   Giouzepas, John ^a   Fokas, Kostas ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Clozapine; Pseydoakathisia; Tardive akathisia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CLOZAPINE; LORAZEPAM; NEUROLEPTIC AGENT; PROPRANOLOL DERIVATIVE; ZIPRASIDONE;

ADULT; AKATHISIA; ARTICLE; CARDIOVASCULAR DISEASE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG SUBSTITUTION; HUMAN; MALE; MENTAL DISEASE; PARANOID SCHIZOPHRENIA; RESTLESSNESS;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; CIRCADIAN RHYTHM; CLOZAPINE; HUMANS; MALE; SCHIZOPHRENIA, PARANOID;

EID: 27844447620     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/3XDY-58PW-6VQX-TQ85     Document Type: Article

References (15)

1. Stahl SM. Essential psychopharmacology (2nd ed.). New York: Cambridge University Press, 2000.
2. Stahl S. Key issues and unmet needs in schizophrenia. In Kapur S, Lecrubier Y, editors. Dopamine in the pathophysiology and treatment of schizophrenia. London: Martin Dunitz, 2003:237-253.
3. 2 receptors as a basis of psychotic effect. In Kapur S, Lecrubier Y, editors. Dopamine in the pathophysiology and treatment of schizophrenia. London: Martin Dunitz, 2003:49-67.
4. Blin O. A comparative review of new antipsychotics. Canadian Journal of Psychiatry 1999;44:235-244.
5. Hector RI. The use of clozapine in the treatment of aggressive schizophrenia. Canadian Journal of Psychiatry 1998;43:466-472.
6. Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Felman JM. Clozapine: A critical review of adverse effects and management. Annals of Clinical Psychiatry 2003;15:33-48.
7. Collaborative Working Group on Clinical Trial Evaluations. Adverse effects of the atypical antipsychotics. Journal of Clinical Psychiatry 1998;59(suppl 12):17-22.
8. Barnes TRE, McPhillips MA. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. British Journal of Psychiatry 1999;174(suppl 38):34-43.
9. Wagstaff AJ, Bryson HM. Clozapine: A review of its pharmacological properties and therapeutic use in patient with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents. CNS Drugs 1995;4:370-400.
10. Owen DGC. A guide to the extrapyramidal side-effects of antipsychotic drugs. New York: Cambridge University Press, 1999.
11. Duncan EJ, Adler LA, Stephanides M, Sanfilipo M, Angrist B. Akathisia and exacerbation of psychopathology: A preliminary report. Clinical Neuropharmacology 2000;23:169-173.
12. Hansen L. A critical review of akathisia, and its possible association with suicidal behaviour. Human Psychopharmacology 2001;16:495-505.
13. Stubbs JH, Halstead M. Pseudoakathisia: A review and two case reports. Comprehensive Psychiatry 2000;41:70-72.
14. Shimizu E, Watanabe H, Iyo M. Delayed-onset nocturnal akathisia due to risperidone and levomepromazine: A case report. European Psychiatry 2002;1:294-295.
15. Gogtay N, Sporn A, Alfaro CL, Mulqueen A, Rapaport JL. Clozapine-induced akathisia in children with schizophrenia. Journal of Child and Adolescent Psychopharmacology 2002;12:347-349.